Reliant Pharmaceuticals Extends Lescol Promotion Agreement

Reliant Pharmaceuticals, Inc. announced that the term of the promotion agreement with Novartis for Lescol (fluvastatin sodium) and Lescol XL (fluvastatin sodium extended-release tablets) will be extended. Reliant began promoting Lescol and Lescol XL in January 2001 under a five-year agreement. Under the terms of the extended agreement, Reliant will continue to promote the Lescol family of products with its national primary care and cardiovascular specialty sales forces through 2007, with the potential to extend through 2008. Either party has the right to terminate the extended term on ninety days notice.

Yahoo News (http://biz.yahoo.com/prnews/050411/nym136.html?.v=5)